T Cell News and Research

Latest T Cell News and Research

TRACON to present data on TRC105, TRC102 cancer therapies at EORTC-NCI-AACR Symposium

TRACON Pharmaceuticals, a biotechnology company that develops targeted therapies for oncology and related diseases, announced today that new data on TRC105 and TRC102 will be presented at the 22nd Annual EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics in Berlin, Germany.

26 Oct 2010

Study reveals two enzymes help immune cells deploy pathogen-killing traps

A new study reveals that two enzymes help immune cells deploy pathogen-killing traps by unraveling and using the chromatin (DNA and its associated proteins) contained in the cells' nuclei to form defensive webs. The study appears online on October 25 in The Journal of Cell Biology.

26 Oct 2010

Maven Semantic updates Lymphocyte Cell Biology research database

Maven Semantic announces updates to their Lymphocyte Cell Biology research database. The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.

26 Oct 2010

Lead exposure may reverse blindness: Research

Some unexpected effects of lead exposure that may one day help prevent and reverse blindness have been uncovered by a University of Houston (UH) professor and his team.

26 Oct 2010

Daily dose of whole body vibration reduces bone density loss

A daily dose of whole body vibration may help reduce the usual bone density loss that occurs with age, Medical College of Georgia researchers report.

25 Oct 2010

Researchers create new high-content assay to increase human embryonic stem cell survival

A new technique for increasing the survival rates of human embryonic stem cells will revolutionize their use in drug discovery and therapy. Human embryonic stem cells often die during the process of isolation using enzymatic disaggregation or low-density plating, which limits their usefulness in drug discovery and basic research. Similarly, the low rate of attachment of implanted cells hinders cell therapy.

25 Oct 2010

Seattle Genetics, Millennium to feature SGN-35 in three poster presentations at ISHL symposium

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced that brentuximab vedotin (SGN-35) will be featured in three poster presentations at the 8th International Symposium on Hodgkin Lymphoma (ISHL) being held October 23-26, 2010 in Cologne, Germany.

25 Oct 2010

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Soligenix, Inc. a late-stage biopharmaceutical company, today reported preliminary results from its Phase 2 "proof-of-concept" exploratory clinical trial of orBec for the prevention of acute Graft-versus-Host disease (GVHD) in patients undergoing myeloablative conditioning regimens with initiation of dosing prior to hematopoietic cell transplantation (HCT) and continuing through the post-transplantation period.

25 Oct 2010

Cryo-Cell to launch new reproductive tissue service for cryopreserved embryos, oocyctes

Cryo-Cell International, Inc. one of the world's largest and most established family cord blood banks and global stem cell innovators, today announced plans at the annual meeting of the American Society of Reproductive Medicine (ASRM) to launch Cryology RTS, a new reproductive tissue storage service for cryopreserved embryos, oocyctes and sperm.

25 Oct 2010

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

Popular Mechanics has recognized three NSF-funded projects with innovation Breakthrough Awards: an artificial retina returning sight to those who have lost it; a system that uses "controlled rocking" and energy-dissipating fuses to help buildings withstand earthquakes; and an inexpensive medical microscope built for cell-phones that allows doctors in rural villages to identify malaria-infected blood cells.

25 Oct 2010

Researchers publish effects of doctor-designed formula against breast cancer

Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies.

25 Oct 2010

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

HRSA has awarded $1.6 million to support the Sickle Cell Disease Treatment Demonstration Program (SCDTDP). The program is designed to establish practice models for the prevention and treatment of sickle cell disease through the coordinated efforts of providers, key stake holders, affected individuals and their families.

25 Oct 2010

FlexBone shows potential replacement for current bone transplantations

With a failure rate as high as 50 percent, bone tissue grafts pose a significant obstacle to orthopedic surgeons attempting to repair complex fractures or large areas of bone loss, such as those often caused by trauma and cancer. Current synthetic substitutes rarely possess the bone-like properties needed for successful grafting and are often difficult for surgeons to manipulate in the operating room. In response to these challenges, researchers at UMass Medical School have developed an easy-to-produce, inexpensive, synthetic bone material called FlexBone.

25 Oct 2010

New gene therapy product reduces plasma cholesterol levels

Amsterdam Molecular Therapeutics (AMT) Holding N.V. a leader in the development of gene based therapies, today announced that its gene therapy product incorporating siRNA sequences into microRNA scaffolds to silence Apolipoprotein B100 (AAV-miApoB) was able to significantly lower plasma cholesterol levels in vivo over a period of 18 weeks. These preliminary results suggest that this approach could lead to a treatment for high cholesterol in humans

25 Oct 2010

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.

25 Oct 2010

NIH awards $3.9M for Fanconi anemia research

The National Institutes of Health has awarded a three-year, $3.9 million grant to Children's Hospital Boston researchers and their colleagues to develop a therapy to treat Fanconi anemia, a fatal genetic blood disease.

25 Oct 2010

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Metabolic syndrome, associated with the sedentary lifestyle and energy dense diet of Western industrialized societies, may be an indicator of breast cancer risk in post-menopausal women, according to a new study to be released at the National Italian American Foundation event, "Let's Talk About It: A Spotlight on Women's Health" on October 22nd at the Washington Hilton in Washington, D.C.

25 Oct 2010

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

Chimerix, Inc., a pharmaceutical company developing orally-available antiviral therapeutics, will present promising clinical data for CMX001 in a late-breaker poster session at the Infectious Diseases Society of America (IDSA) 48th Annual Meeting.

25 Oct 2010

BAFF protein can promote aggressive leukemia and lymphomas

Chronic lymphocytic leukemia (CLL) cells survive and thrive not just by their own innate wiles, but by also acquiring aid and support from host cells in their surrounding environment.

25 Oct 2010

Cellectis and CiRA commence iPS cell scientific collaboration

Cellectis, the French genome engineering specialist, and the Center for iPS Cells Research and Application (CiRA) of Kyoto University, Kyoto, Japan, have announced today that they have started a scientific collaboration to combine Cellectis' genome engineering technologies with CiRA's induced pluripotent stem cell (iPS) technology to improve the natural characteristics of iPS cells for use as cellular tools.

25 Oct 2010

T Cell News and Research

Latest T Cell News and Research

TRACON to present data on TRC105, TRC102 cancer therapies at EORTC-NCI-AACR Symposium

Study reveals two enzymes help immune cells deploy pathogen-killing traps

Maven Semantic updates Lymphocyte Cell Biology research database

Lead exposure may reverse blindness: Research

Daily dose of whole body vibration reduces bone density loss

Researchers create new high-content assay to increase human embryonic stem cell survival

Seattle Genetics, Millennium to feature SGN-35 in three poster presentations at ISHL symposium

Soligenix reports Phase 2 clinical trial results of orBec for GVHD

Cryo-Cell to launch new reproductive tissue service for cryopreserved embryos, oocyctes

Popular Mechanics recognizes three NSF-funded projects with innovation Breakthrough Awards

Researchers publish effects of doctor-designed formula against breast cancer

HRSA supports Sickle Cell Disease Treatment Demonstration Program with $1.6M award

FlexBone shows potential replacement for current bone transplantations

New gene therapy product reduces plasma cholesterol levels

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

NIH awards $3.9M for Fanconi anemia research

Study finds metabolic syndrome may indicate breast cancer risk in post-menopausal women

Chimerix to present CMX001 data for viral infections at IDSA Annual Meeting

BAFF protein can promote aggressive leukemia and lymphomas

Cellectis and CiRA commence iPS cell scientific collaboration

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in